HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SB2 infliximab

an infliximab (IFX) biosimilar to the reference infliximab (R.I.) product (Remicade)

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	De Angelis, Giulia: 1 article (01/2020)
2.	Di Paolo, Maria Carla: 1 article (01/2020)
3.	Graziani, Maria Giovanna: 1 article (01/2020)
4.	Milano, Michele: 1 article (01/2020)
5.	Pagnini, Cristiano: 1 article (01/2020)
6.	Porciello, Roberto: 1 article (01/2020)
7.	Torcolacci, Federica: 1 article (01/2020)
8.	Trinca, Daniela: 1 article (01/2020)

Related Diseases

1.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/01/2017 - "A SPECIAL MEETING REVIEW EDITION: Highlights in Biosimilars From the World Congress of Gastroenterology at ACG 2017: Introduction: A Review of Selected Presentations From the World Congress of Gastroenterology at ACG 2017 • October 13-18, 2017 • Orlando, FloridaSpecial Reporting on:• Biosimilars: What Are They and How Will They Change the Way We Practice?• Infliximab Assay Used in Clinical Practice Validated for Measuring SB2 Infliximab Biosimilar's Serum Drug and Anti-Drug Antibody Levels• Efficacy of Infliximab Biosimilar for Induction and Maintenance Therapy in Inflammatory Bowel Disease After Switch From Drug Originator: A Meta-Analysis• Long-Term Efficacy, Safety, and Immunogenicity Data From a Phase III Confirmatory Study Comparing GP2017, a Proposed Biosimilar, With Reference Adalimumab• Patient Perceptions Regarding the Use of Biosimilars in Inflammatory Bowel Disease• FDA Public Forum on BiosimilarsWith an Introduction and Expert Commentary by:Gary R. "
2.	Psoriasis (Pustulosis Palmaris et Plantaris) 01/01/2020 - "Similar But Not Identical: Plaque Psoriasis Exacerbation in a Patient With Crohn's Disease After Switching From CT-P13 to SB2 Infliximab Biosimilar."
3.	Crohn Disease (Crohn's Disease) 01/01/2020 - "Similar But Not Identical: Plaque Psoriasis Exacerbation in a Patient With Crohn's Disease After Switching From CT-P13 to SB2 Infliximab Biosimilar."

Related Drugs and Biologics

1.	Biosimilar Pharmaceuticals
2.	Infliximab (Remicade)
3.	acceleratory factor from growth hormone (AcG)
4.	GP2017
5.	CT-P13

Related Therapies and Procedures

1.	Therapeutics